Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is positioned for continued robust growth, particularly within its Evernorth segment, which is expected to enhance patient satisfaction while driving lower costs and improved health outcomes. The company anticipates significant margin recovery by 2027, with a projected 100 basis points recapture for its healthcare portfolio, contributing to long-term growth expectations of 7%-10% in the Healthcare segment. Furthermore, strong free cash flow is expected to support ongoing capital deployment, broadening service offerings and sustaining core growth trends, thereby presenting a favorable valuation outlook for the stock.

Bears say

Cigna Group faces significant financial challenges as it anticipates a decline in Evernorth Adjusted Operating Income (AOI) for 2026, primarily due to pressures from pharmacy benefit management (PBM) margins and the impact of transitioning to a rebate-free model, which is expected to reduce earnings by $500 million to $600 million. Moreover, the expected decline in AOI margins among its top three customers and the overall shift to lower-priced contracts present further margin erosion risks. Additionally, Cigna's outlook is clouded by potential client losses, competitive pressures within the specialty drug market, and uncertainties regarding healthcare cost management in the U.S. market.

Cigna (CI) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 14 analysts, Cigna (CI) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $350.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $350.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.